🔎 Trials Near Me

Home › Melanoma › NCT07556380

Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions

Recruiting

SESAME: Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Is able to speak, read and write in English
* Had previous melanoma diagnosis with no melanoma treatment in the last three months
* Has no current Melanomas or untreated skin cancer
* Reports spending at least 15 minutes outside per day during Spring/ Summer on both weekdays and weekends
* Owns a smartphone with access to both Bluetooth and WIFI
* Is willing to use the UV device and Actigraph during waking hours
* Is willing to download and use a study app
* Is willing to actively participate in the study for up to 1 year

Exclusion Criteria:

* Has a medical condition preventing moderate-to-vigorous physical activity (MVPA) or a doctor recommendation to avoid MVPA
* Is currently enrolled in another study on MVPA

About the study

The purpose of this study is to evaluate 5 different smartphone administered sun protection interventions that aim to reduce unprotected sun exposure in melanoma survivors. Participants are asked to wear an ultraviolet (UV) device and an activity monitor (Actigraph) to measure their daily UV exposure and track their physical activity for three separate assessment weeks and complete daily surveys. After the first assessment week, eligible participants are assigned up to 5 different sun protection interventions that are administered through a smartphone application for 8 weeks. Following 8-week use of the sun protection interventions, participants complete another assessment week. At the end of the assessment week, participants provide feedback on the design and usability of the UV device, smartphone application and each of the sun protection interventions that they experienced. One year later, participants are contacted again to complete a final assessment week.

What is being tested

Sponsor: Northwestern University · Participants: 150 · Started: Apr 1, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT07556380

Locations in the U.S.

IllinoisNorthwestern University, Chicago
UtahHuntsman Cancer Institute at The University of Utah, Salt Lake City

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.